A phase 1b study of once-weekly carfilzomib combined with lenalidomide and dexamethasone (wKRd) in patients (pts) with newly diagnosed multiple myeloma (NDMM)

Authors :: William I. Bensinger
David S. Siegel
Amy S. Kimball
Jesus G. Berdeja
Melissa Alsina
Ruben Niesvizky
Tibor Kovacsovics
Belle Fang
Noopur Raje
C. Ola Landgren
David H. Vesole
Source :: Clinical Lymphoma Myeloma and Leukemia. 19:e52
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Once weekly
Hematology
Newly diagnosed
medicine.disease
Carfilzomib
chemistry.chemical_compound
chemistry
Internal medicine
medicine
In patient
business
Multiple myeloma
Dexamethasone
Lenalidomide
medicine.drug

Tools